Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1106 | 992 | 1153 | 1255 | 1310 | 1817 |
Fund Return | 10.56% | -0.84% | 15.33% | 7.86% | 5.55% | 6.15% |
Place in category | 272 | 302 | 243 | 210 | 174 | 78 |
% in Category | 45 | 49 | 39 | 41 | 38 | 21 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HSBC American Index Fund Accumulati | 16.65B | 27.12 | 12.01 | 15.27 | ||
HSBC American Index Fund Income C | 16.65B | 27.10 | 12.01 | 15.26 | ||
HSBC American Index Fund Retail Acc | 16.65B | 27.03 | 11.92 | 15.17 | ||
HSBC American Index Fund Retail Inc | 16.65B | 27.01 | 12.40 | 15.30 | ||
HSFund Institutional Accumulation | 16.65B | 27.15 | 12.05 | 15.33 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Index Unit Trust Accumulation | 14.69B | 11.13 | 7.80 | 6.10 | ||
All Share Index Unit Trust Income | 14.69B | 11.14 | 7.78 | 6.09 | ||
VG UK Plus GBP Accumulation | 14.69B | 11.14 | 7.80 | 6.12 | ||
VG UK Institutional Plus GBP Income | 14.69B | 11.15 | 7.79 | 6.11 | ||
UK Equity Tracker Fund D Acc | 11.63B | 10.48 | 8.11 | 6.25 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 6.52 | 31.29 | +1.56% | |
AstraZeneca | GB0009895292 | 6.48 | 10,594.0 | -0.34% | |
HSBC | GB0005405286 | 5.54 | 782.30 | -0.14% | |
Unilever | GB00B10RZP78 | 4.76 | 54.98 | -0.69% | |
Relx | GB00B2B0DG97 | 2.82 | 3,650.00 | -0.82% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | BUY | Strong Buy |
Summary | Strong Buy | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review